Koyfin Home > Directory > Health Care > Aquestive Therapeutics Inc > Cash Flow from Operations

Aquestive Therapeutics Inc Cash Flow from Operations Chart (AQST)

Aquestive Therapeutics Inc annual/quarterly Cash Flow from Operations from 2006 to 2018. Cash flow from operating activities (CFO) is an accounting item that indicates the amount of money a company brings in from ongoing, regular business activities, such as manufacturing and selling goods or providing a service. Cash flow from operating activities does not include long-term capital or investment costs.
  • Aquestive Therapeutics Inc Cash Flow from Operations for the quarter ending September 09, 2018 was $-11m a 35.43% decrease of -4m year over year
  • Aquestive Therapeutics Inc Cash Flow from Operations for the last 12 months ending September 09, 2018 was $-18m a 133.11% decrease of -23m year over year
  • Aquestive Therapeutics Inc Annual Cash Flow from Operations for 2017 was $6m a 240.37% increase of 14m from 2016
  • Aquestive Therapeutics Inc Annual Cash Flow from Operations for 2016 was $-8m a -13.21% increase of 1m from 2015
  • Aquestive Therapeutics Inc Annual Cash Flow from Operations for 2006 was $-9m a 30.90% decrease of -3m from 2005
Other Cash Flow Metrics:
  • Aquestive Therapeutics Inc Levered Free Cash Flow (FCF) for the quarter ending September 09, 2018 was $-6m a 59.44% decrease of -4m year over year
  • Aquestive Therapeutics Inc Total Revenue for the quarter ending December 12, 2018 was $17m a -39.15% decrease of -7m year over year
View Chart On Koyfin

Quarterly AQST Cash Flow from Operations Data

09/2018$-11m
06/2018$1m
03/2018$1m
12/2017$-7m
09/2017$16m
06/2017$-6m
03/2017$4m
06/2007$-3m
03/2007$-3m
12/2006$-3m

Annual AQST Cash Flow from Operations Data

2017$6m
2016$-8m
2006$-9m
2005$-6m
2004$-3m